P50 | author | Milena Penkowa | Q3378367 |
| | Juan Hidalgo | Q37379782 |
P2860 | cites work | Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase | Q27933522 |
| | IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment | Q28377943 |
| | Effect of non-toxic mercury, zinc or cadmium pretreatment on the capacity of human monocytes to undergo lipopolysaccharide-induced activation | Q28378867 |
| | Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice | Q31430351 |
| | Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis | Q33642743 |
| | Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha | Q33771960 |
| | Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. | Q34153407 |
| | Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide | Q34334574 |
| | Molecular profile of reactive astrocytes--implications for their role in neurologic disease | Q34366853 |
| | Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells | Q36231527 |
| | Evidence for a protective role of metallothionein-1 in focal cerebral ischemia | Q36561063 |
| | Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease | Q40411063 |
| | Metallothioneins and cell death by anticancer drugs | Q40437026 |
| | Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells | Q40944429 |
| | Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis | Q41433234 |
| | Activation of human monocytes with lipopolysaccharide induces metallothionein expression and is diminished by zinc | Q41496402 |
| | Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes | Q42490264 |
| | Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin | Q45785851 |
| | Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis. | Q45937546 |
| | Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: effects of macrophage enrichment | Q46845557 |
| | The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs | Q47785517 |
| | IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein | Q47914546 |
| | Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice | Q48035745 |
| | Activated non-neural specific T cells open the blood-brain barrier to circulating antibodies | Q48174524 |
| | Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice | Q48245297 |
| | Effect of nitric oxide synthesis inhibition on mouse liver and brain metallothionein expression | Q48251392 |
| | Effect of reactive oxygen species on myelin membrane proteins | Q48448702 |
| | Increased astrocytic expression of metallothioneins I + II in brainstem of adult rats treated with 6-aminonicotinamide | Q48549874 |
| | Reactive oxygen species in experimental allergic encephalomyelitis | Q48712953 |
| | Selective degeneration of oligodendrocytes mediated by reactive oxygen species. | Q50884032 |
| | Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains. | Q53338345 |
| | IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. | Q54070701 |
P5824 | is retracted by | Retracted: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis | Q56240171 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
P304 | page(s) | 247-63 | |
P577 | publication date | 2000-12-01 | |
P1433 | published in | Glia | Q15716658 |
P1476 | title | RETRACTED: Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis | |
P478 | volume | 32 | |